癌症中的抗原呈现 - 免疫治疗的机制和临床影响
Kailin Yang1, Ahmed Halima1, Timothy A Chan2,3,4,5
1Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Nature reviews. Clinical oncology
|June 16, 2023
概括
有效的免疫疗法彻底改变了癌症治疗,但并非所有患者都能从中长期受益. 了解抗原呈现机制 (APM) 机制是改善癌症免疫疗法反应和克服抗性的关键.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 免疫疗法已经改变了癌症护理,但持久的反应仍然局限于一小部分患者.
- 识别治疗反应和耐药性的机制对于提高免疫疗法的疗效至关重要.
研究的目的:
- 审查瘤中抗原处理和呈现 (APP) 的分子机制.
- 探索APP机制 (APM) 如何影响瘤免疫力和临床结果.
- 突出影响APM的基因组变化及其对免疫治疗反应的影响.
主要方法:
- 对APP分子机制的当前文献的综述.
- 对HLA等位基因和APM组件中的基因组变异的分析.
- 检查癌症和免疫细胞中的免疫皮体变化.
主要成果:
- 包括HLA等位基因在内的APM组件的基因组变异显著影响瘤免疫性.
- 在APM的变化塑造瘤微环境和影响免疫细胞的相互作用.
- 瘤中的特定分子和基因组变化与患者对免疫检查点抑制剂的反应和耐药性相关.
结论:
- 了解APM对于预测患者对免疫疗法的反应和识别耐药机制至关重要.
- 针对APM及其变异为开发新型免疫治疗策略提供了潜力.
- 准确的免疫疗法可以通过对APM介导的瘤免疫相互作用的更深入的知识来指导.
相关概念视频
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Cancer Vaccines
434
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
434
T Cell Activation and Clonal Selection
837
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
837
Antigen Presenting Cells
1.9K
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
1.9K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


